References
- Berendsen, H. J. C., van der Spoel, D., & van Drunen, R. (1995). GROMACS: A message-passing parallel molecular dynamics implementation. Computer Physics Communications, 91(1–3), 43–56. https://doi.org/https://doi.org/10.1016/0010-4655(95)00042-E
- Bockelman, C., Koskensalo, S., Hagstrom, J., Lundin, M., Ristimaki, A., & Haglund, C. (2012). CIP2A overexpression is associated with c-Myc expression in colorectal cancer. Cancer Biology & Therapy, 13(5), 289–295. https://doi.org/https://doi.org/10.4161/cbt.18922
- Côme, C., Laine, A., Chanrion, M., Edgren, H., Mattila, E., Liu, X., Jonkers, J., Ivaska, J., Isola, J., Darbon, J.-M., Kallioniemi, O., Thézenas, S., & Westermarck, J. (2009). CIP2A is associated with human breast cancer aggressivity. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 15(16), 5092–5100. https://doi.org/https://doi.org/10.1158/1078-0432.CCR-08-3283
- Cukuroglu, E., Engin, H. B., Gursoy, A., & Keskin, O. (2014). Hot spots in protein-protein interfaces: towards drug discovery. Progress in Biophysics and Molecular Biology, 116(2-3), 165–173. https://doi.org/https://doi.org/10.1016/j.pbiomolbio.2014.06.003
- De, P., Carlson, J., Leyland-Jones, B., & Dey, N. (2014). Oncogenic nexus of cancerous inhibitor of protein phosphatase 2A (CIP2A): An oncoprotein with many hands. Oncotarget, 5(13), 4581–4602. https://doi.org/https://doi.org/10.18632/oncotarget.2127
- Delano, W. L. (2019). The PyMOL Molecular Graphics System. http://www.pymol.org
- Discovery Studio. (2016). Dassault Systèmes BIOVIA. www.3ds.com
- Dong, Q. Z., Wang, Y., Dong, X. J., Li, Z. X., Tang, Z. P., Cui, Q. Z., & Wang, E. H. (2011). CIP2A is overexpressed in non-small cell lung cancer and correlates with poor prognosis. Annals of Surgical Oncology, 18(3), 857–865. https://doi.org/https://doi.org/10.1245/s10434-010-1313-8
- Friesner, R. A., Murphy, R. B., Repasky, M. P., Frye, L. L., Greenwood, J. R., Halgren, T. A., Sanschagrin, P. C., & Mainz, D. T. (2006). Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. Journal of Medicinal Chemistry, 49(21), 6177–6196. https://doi.org/https://doi.org/10.1021/jm051256o
- Gurung, A. B., Bhattacharjee, A., Ajmal Ali, M., Al-Hemaid, F., & Lee, J. (2017). Binding of small molecules at interface of protein-protein complex - A newer approach to rational drug design. Saudi Journal of Biological Sciences, 24(2), 379–388. https://doi.org/https://doi.org/10.1016/j.sjbs.2016.01.008
- Harder, E., Damm, W., Maple, J., Wu, C., Reboul, M., Xiang, J. Y., Wang, L., Lupyan, D., Dahlgren, M. K., Knight, J. L., Kaus, J. W., Cerutti, D. S., Krilov, G., Jorgensen, W. L., Abel, R., & Friesner, R. A. (2016). OPLS3: A force field providing broad coverage of drug-like small molecules and proteins. Journal of Chemical Theory and Computation, 12(1), 281–296. https://doi.org/https://doi.org/10.1021/acs.jctc.5b00864
- Huang, L. P., Adelson, M. E., Mordechai, E., & Trama, J. P. (2010). CIP2A expression is elevated in cervical cancer. Cancer Biomarkers: Biomarkers, 8(6), 309–317. https://doi.org/https://doi.org/10.3233/CBM-2011-0220
- Junttila, M. R., & Westermarck, J. (2008). Mechanisms of MYC stabilization in human malignancies. Cell Cycle (Georgetown, Tex.), 7(5), 592–596. https://doi.org/https://doi.org/10.4161/cc.7.5.5492
- Junttila, M. R., Puustinen, P., Niemelä, M., Ahola, R., Arnold, H., Böttzauw, T., Ala-Aho, R., Nielsen, C., Ivaska, J., Taya, Y., Lu, S.-L., Lin, S., Chan, E. K. L., Wang, X.-J., Grènman, R., Kast, J., Kallunki, T., Sears, R., Kähäri, V.-M., & Westermarck, J. (2007). CIP2A inhibits PP2A in human malignancies. Cell, 130(1), 51–62. https://doi.org/https://doi.org/10.1016/j.cell.2007.04.044
- Katz, J., Jakymiw, A., Ducksworth, M. K., Stewart, C. M., Bhattacharyya, I., Cha, S., & Chan, E. K. (2010). CIP2A expression and localization in oral carcinoma and dysplasia. Cancer Biology & Therapy, 10(7), 694–699. https://doi.org/https://doi.org/10.4161/cbt.10.7.12895
- Khanna, A., Böckelman, C., Hemmes, A., Junttila, M. R., Wiksten, J.-P., Lundin, M., Junnila, S., Murphy, D. J., Evan, G. I., Haglund, C., Westermarck, J., & Ristimäki, A. (2009). MYC-dependent regulation and prognostic role of CIP2A in gastric cancer. Journal of the National Cancer Institute, 101(11), 793–805. https://doi.org/https://doi.org/10.1093/jnci/djp103
- Khanna, A., Pimanda, J. E., & Westermarck, J. (2013). Cancerous inhibitor of protein phosphatase 2A, an emerging human oncoprotein and a potential cancer therapy target. Cancer Research, 73(22), 6548–6553. https://doi.org/https://doi.org/10.1158/0008-5472.CAN-13-1994
- Kumari, R., Kumar, R., & Lynn, A, Open Source Drug Discovery Consortium. (2014). g_mmpbsa-a GROMACS tool for high-throughput MM-PBSA calculations. Journal of Chemical Information and Modeling, 54(7), 1951–1962. https://doi.org/https://doi.org/10.1021/ci500020m
- Kumavath, R., Azad, M., Devarapalli, P., Tiwari, S., Kar, S., Barh, D., Azevedo, V., & Kumar, A. P. (2016). Novel aromatase inhibitors selection using induced fit docking and extra precision methods: Potential clinical use in ER-alpha-positive breast cancer. Bioinformation, 12(6), 324–331. https://doi.org/https://doi.org/10.6026/97320630012324
- Kutzner, C., Páll, S., Fechner, M., Esztermann, A., de Groot, B. L., & Grubmüller, H. (2019). More bang for your buck: Improved use of GPU nodes for GROMACS 2018. Journal of Computational Chemistry, 40(27), 2418–2431. https://doi.org/https://doi.org/10.1002/jcc.26011
- Li, W., Ge, Z., Liu, C., Liu, Z., Bjorkholm, M., Jia, J., & Xu, D. (2008). CIP2A is overexpressed in gastric cancer and its depletion leads to impaired clonogenicity, senescence, or differentiation of tumor cells. Clinical Cancer Research, 14(12), 3722–3728. https://doi.org/https://doi.org/10.1158/1078-0432.CCR-07-4137
- Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 46(1–3), 3–26. https://doi.org/https://doi.org/10.1016/j.addr.2012.09.019
- Liu, J., Wang, X., Zhou, G., Wang, H., Xiang, L., Cheng, Y., Liu, W., Wang, Y., Jia, J., & Zhao, W. (2011). Cancerous inhibitor of protein phosphatase 2A is overexpressed in cervical cancer and upregulated by human papillomavirus 16 E7 oncoprotein. Gynecologic Oncology, 122(2), 430–436. https://doi.org/https://doi.org/10.1016/j.ygyno.2011.04.031
- Lu, L., Hu, H., Hou, H., & Wang, B. (2013). An improved B3LYP method in the calculation of organic thermochemistry and reactivity. Computational and Theoretical Chemistry, 1015, 64–71. https://doi.org/https://doi.org/10.1016/j.comptc.2013.04.009
- MolSoft ICM-pro. (2019). Program Manual. ICM Molsoft L.L.C. www.molsoft.com
- Price, D. J., & Brooks, C. L. 3rd. (2004). A modified TIP3P water potential for simulation with Ewald summation. The Journal of Chemical Physics, 121(20), 10096–10103. https://doi.org/https://doi.org/10.1063/1.1808117
- Puustinen, P., & Jaattela, M. (2014). KIAA1524/CIP2A promotes cancer growth by coordinating the activities of MTORC1 and MYC. Autophagy, 10(7), 1352–1354. https://doi.org/https://doi.org/10.4161/auto.29076
- Qu, W., Li, W., Wei, L., Xing, L., Wang, X., & Yu, J. (2012). CIP2A is overexpressed in esophageal squamous cell carcinoma. Medical Oncology, 29(1), 113–118. https://doi.org/https://doi.org/10.1007/s12032-010-9768-9
- Rognan, D. (2015). Rational design of protein–protein interaction inhibitors. MedChemComm, 6(1), 51–60. https://doi.org/https://doi.org/10.1039/C4MD00328D
- Schrödinger. (2019). LLC. www.schrodinger.com
- Shelley, J. C., Cholleti, A., Frye, L. L., Greenwood, J. R., Timlin, M. R., & Uchimaya, M. (2007). Epik: A software program for pK( a ) prediction and protonation state generation for drug-like molecules. Journal of Computer-Aided Molecular Design, 21(12), 681–691. https://doi.org/https://doi.org/10.1007/s10822-007-9133-z
- Sherman, W., Beard, H. S., & Farid, R. (2006). Use of an induced fit receptor structure in virtual screening. Chemical Biology & Drug Design, 67(1), 83–84. https://doi.org/https://doi.org/10.1111/j.1747-0285.2005.00327.x
- Sindhu, T., & Srinivasan, P. (2015). Exploring the binding properties of agonists interacting with human TGR5 using structural modeling, molecular docking and dynamics simulations. RSC Advances, 5(19), 14202–14213. https://doi.org/https://doi.org/10.1039/C4RA16617E
- Teng, H.-W., Yang, S.-H., Lin, J.-K., Chen, W.-S., Lin, T.-C., Jiang, J.-K., Yen, C.-C., Li, A. F.-Y., Chen, P. C.-H., Lan, Y.-T., Lin, C.-C., Hsu, Y.-N., Wang, H.-W., & Chen, K.-F. (2012). CIP2A is a predictor of poor prognosis in colon cancer. Journal of Gastrointestinal Surgery, 16(5), 1037–1047. https://doi.org/https://doi.org/10.1007/s11605-012-1828-3
- Tirado-Rives, J., & Jorgensen, W. L. (2008). Performance of B3LYP Density Functional Methods for a Large Set of Organic Molecules. Journal of Chemical Theory and Computation, 4(2), 297–306. https://doi.org/https://doi.org/10.1021/ct700248k
- Tuncbag, N., Keskin, O., & Gursoy, A. (2010). HotPoint: Hot spot prediction server for protein interfaces. Nucleic Acids Research, 38(Web Server issue), W402–406. https://doi.org/https://doi.org/10.1093/nar/gkq323
- Vaarala, M. H., Vaisanen, M. R., & Ristimaki, A. (2010). CIP2A expression is increased in prostate cancer. Journal of Experimental & Clinical Cancer Research, 29(1), 136. https://doi.org/https://doi.org/10.1186/1756-9966-29-136
- Wang, J., Okkeri, J., Pavic, K., Wang, Z., Kauko, O., Halonen, T., Sarek, G., Ojala, P. M., Rao, Z., Xu, W., & Westermarck, J. (2017). Oncoprotein CIP2A is stabilized via interaction with tumor suppressor PP2A/B56. EMBO Reports, 18(3), 437–450. https://doi.org/https://doi.org/10.15252/embr.201642788
- Xue, Y., Wu, G., Wang, X., Zou, X., Zhang, G., Xiao, R., Yuan, Y., Long, D., Yang, J., Wu, Y., Xu, H., Liu, F., & Liu, M. (2013). CIP2A is a predictor of survival and a novel therapeutic target in bladder urothelial cell carcinoma. Medical Oncology, 30(1), 406. https://doi.org/https://doi.org/10.1007/s12032-012-0406-6
- Zoete, V., Cuendet, M. A., Grosdidier, A., & Michielin, O. (2011). SwissParam: a fast force field generation tool for small organic molecules. Journal of Computational Chemistry, 32(11), 2359–2368. https://doi.org/https://doi.org/10.1002/jcc.21816